Omnicell has been granted a patent for a robotic compounding system that includes a cartridge for loading tamper-evident syringe caps into a pharmaceutical device. The system features a syringe finishing station and a cartridge with an angled floor for gravity-fed cap transfer. The cartridge also includes a door that automatically closes when removed from the system. GlobalData’s report on Omnicell gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Access deeper industry intelligence
Experience unmatched clarity with a single platform that combines unique data, AI, and human expertise.
According to GlobalData’s company profile on Omnicell, Automated drug dispensing systems was a key innovation area identified from patents. Omnicell's grant share as of May 2024 was 51%. Grant share is based on the ratio of number of grants to total number of patents.
Robotic system for loading tamper-evident syringe caps
A recently granted patent (Publication Number: US11980748B2) discloses a robotic compounding system designed to automate the process of placing tamper-evident syringe caps onto syringes. The system includes a syringe finishing station with an input location for receiving and placing the caps, and a cartridge that holds the caps and facilitates their movement towards the station. The cartridge features an angled floor and a door that automatically closes when removed from the system, ensuring efficient cap dispensing.
Furthermore, the system incorporates a vibratory element to assist in moving the caps towards the outlet of the cartridge, enhancing the overall automation process. The syringe finishing station is equipped with a rotating mechanism for placing the caps on syringes and a gate controlled by an actuator to regulate the cap dispensing process. The design also includes rails for easy insertion and removal of the cartridge, streamlining the operation of the robotic compounding system. These innovative features aim to improve efficiency and accuracy in compounding pharmaceuticals, catering to the growing demand for automated solutions in the healthcare industry.
To know more about GlobalData’s detailed insights on Omnicell, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
